KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

Astrana Health (ASTH) Non-Current Receivables (2016 - 2025)

Astrana Health's Non-Current Receivables history spans 9 years, with the latest figure at $48.5 million for Q3 2025.

  • For Q3 2025, Non-Current Receivables rose 204.05% year-over-year to $48.5 million; the TTM value through Sep 2025 reached $48.5 million, up 204.05%, while the annual FY2024 figure was $15.9 million, 0.0% changed from the prior year.
  • Non-Current Receivables for Q3 2025 was $48.5 million at Astrana Health, up from $15.9 million in the prior quarter.
  • Across five years, Non-Current Receivables topped out at $48.5 million in Q3 2025 and bottomed at $518000.0 in Q3 2022.
  • The 5-year median for Non-Current Receivables is $15.9 million (2021), against an average of $14.9 million.
  • The largest annual shift saw Non-Current Receivables tumbled 86.7% in 2022 before it soared 4733.98% in 2023.
  • A 5-year view of Non-Current Receivables shows it stood at $15.9 million in 2021, then plummeted by 96.75% to $518000.0 in 2022, then surged by 2977.8% to $15.9 million in 2023, then changed by 0.0% to $15.9 million in 2024, then skyrocketed by 204.05% to $48.5 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Non-Current Receivables are $48.5 million (Q3 2025), $15.9 million (Q4 2024), and $15.9 million (Q3 2024).